Abstract
Pluripotent stem cells can be genetically labeled to facilitate differentiation studies. In this paper, we describe a gene-targeting protocol to knock in a GFP cassette into key gene loci in human pluripotent stem cells (hPSCs), and then use the genetically tagged hPSCs to guide in vitro differentiation, immunocytochemical and electrophysiological profiling and in vivo characterization after cell transplantation. The Olig transcription factors have key roles in the transcription regulatory pathways for the genesis of motor neurons (MNs) and oligodendrocytes (OLs). We have generated OLIG2-GFP hPSC reporter lines that reliably mark MNs and OLs for monitoring their sequential differentiation from hPSCs. The expression of the GFP reporter recapitulates the endogenous expression of OLIG genes. The in vitro characterization of fluorescence-activated cell sorting-purified cells is consistent with cells of the MN or OL lineages, depending on the stages at which they are collected. This protocol is efficient and reliable and usually takes 5–7 months to complete. The genetic tagging-differentiation methodology used herein provides a general framework for similar work for differentiation of hPSCs into other lineages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lu, Q.R. et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109, 75–86 (2002).
Zhou, Q. & Anderson, D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61–73 (2002).
Lee, S.K., Lee, B., Ruiz, E.C. & Pfaff, S.L. Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Genes Dev. 19, 282–294 (2005).
Wang, S.Z. et al. An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development 133, 3389–3398 (2006).
Deneen, B. et al. The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron 52, 953–968 (2006).
Xue, H. et al. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells 27, 1836–1846 (2009).
Jiang, P. et al. Electrophysiological properties of human induced pluripotent stem cells. Am. J. Physiol. Cell Physiol. 298, C486–C495 (2010).
Jiang, P., Selvaraj, V. & Deng, W. Differentiation of embryonic stem cells into oligodendrocyte precursors. J. Vis. Exp., doi:10.3791/1960 (2010).
Zou, J. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97–110 (2009).
Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851–857 (2009).
Song, H., Chung, S.K. & Xu, Y. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 80–89 (2010).
Davis, R.P. et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111, 1876–1884 (2008).
Ruby, K.M. & Zheng, B. Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 27, 1496–1506 (2009).
Hu, B.Y., Du, Z.W., Li, X.J., Ayala, M. & Zhang, S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443–1452 (2009).
Hu, B.Y., Du, Z.W. & Zhang, S.C. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat. Protoc. 4, 1614–1622 (2009).
Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007).
Liu, Y. et al. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 40, 25–43 (2002).
Campanelli, J.T. et al. Expression profiling of human glial precursors. BMC Dev. Biol. 8, 102 (2008).
Cummins, T.R., Rush, A.M., Estacion, M., Dib-Hajj, S.D. & Waxman, S.G. Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Nat. Protoc. 4, 1103–1112 (2009).
Wu, S., Ying, G., Wu, Q. & Capecchi, M.R. A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond. Nat. Protoc. 3, 1056–1076 (2008).
Davis, R.P. et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat. Protoc. 3, 1550–1558 (2008).
Costa, M. et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat. Protoc. 2, 792–796 (2007).
Li, X.J. et al. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 26, 886–893 (2008).
Hu, B.Y. & Zhang, S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc 4, 1295–1304 (2009).
Li, X.J. et al. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215–221 (2005).
Sinha, S. & Chen, J.K. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat. Chem. Biol. 2, 29–30 (2006).
Acknowledgements
This work was supported by the California Institute for Regenerative Medicine (CIRM, RT1-01107-1 to Y.L.), the National Institutes of Health (R01NS061983 and R01ES015988 to W.D.), the National Multiple Sclerosis Society (to W.D.) and by Shriners Hospitals for Children (to W.D.). P.J. is a recipient of a postdoctoral fellowship from Shriners Hospitals for Children. Y.L. thanks H. Xue for technical assistance; J. Loring, L. Laurent and M. Rao for support; B. Ranscht (Sanford-Burnham Medical Research Institute) for the GalC antibody; and the CIRM shared laboratory at the Scripps Research Institute for providing accommodation and facilities.
Author information
Authors and Affiliations
Contributions
Y.L., P.J. and W.D. designed the experiments, and wrote and finally approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Liu, Y., Jiang, P. & Deng, W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat Protoc 6, 640–655 (2011). https://doi.org/10.1038/nprot.2011.310
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2011.310
This article is cited by
-
Generation of oligodendrocytes and establishment of an all-human myelinating platform from human pluripotent stem cells
Nature Protocols (2020)
-
Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain
Nature Communications (2020)
-
Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro
Stem Cell Research & Therapy (2019)
-
Modeling neurological diseases using iPSC-derived neural cells
Cell and Tissue Research (2018)
-
High yield extraction of pure spinal motor neurons, astrocytes and microglia from single embryo and adult mouse spinal cord
Scientific Reports (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.